作者
Andrew TL Ong, Patrick W Serruys, Jiro Aoki, Angela Hoye, Carlos AG van Mieghem, Gaston A Rodriguez-Granillo, Marco Valgimigli, Karel Sonnenschein, Evelyn Regar, Martin van der Ent, Peter PT de Jaegere, Eugene P McFadden, Georgios Sianos, Willem J van der Giessen, Pim J de Feyter, Ron T van Domburg
发表日期
2005/4/5
期刊
Journal of the American College of Cardiology
卷号
45
期号
7
页码范围
1135-1141
出版商
American College of Cardiology Foundation
简介
Objectives
We investigated the efficacy of paclitaxel-eluting stents (PES) compared to sirolimus-eluting stents (SES) when used without restriction in unselected patients.
Background
Both SES and PES have been separately shown to be efficacious when compared to bare stents. In unselected patients, no direct comparison between the two devices has been performed.
Methods
Paclitaxel-eluting stents have been used as the stent of choice for all percutaneous coronary interventions in the prospective Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registry. A total of 576 consecutive patients with de novo coronary artery disease exclusively treated with PES were compared with 508 patients treated with SES from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
Results
The PES patients were more frequently male, more frequently treated for acute …
引用总数
200520062007200820092010201120122013201420152016201720182019202020212022187349352024252191115322121